Diversion and counterfeits
Grey-market and falsified medicines erode trust — and put patients at direct risk.

Industry
Patient-safe traceability from manufacture to dispense — without bespoke integrations for every partner.
Why Haloglide
When the product is a medicine, a vaccine or an implantable device, traceability stops being a compliance line item and becomes a patient-safety one. Diversion, falsification and slow recall execution all carry real human cost.
Haloglide gives manufacturers, distributors, hospitals and pharmacies a single, standards-based source of truth — aligned with GS1, EPCIS 2.0, DSCSA, EU FMD and the equivalent frameworks emerging worldwide. No proprietary lock-in. No silent black boxes.
Industry challenges
Grey-market and falsified medicines erode trust — and put patients at direct risk.
Identifying every affected lot across distributors, hospitals and pharmacies is slow, manual and error-prone.
Trading partners run different systems and dialects. EPCIS exchange becomes painful and bespoke.
How Haloglide helps
Serialised identity for every saleable unit — aligned with GS1 SGTIN and Digital Link.
Immutable EPCIS 2.0 event history across manufacturing, distribution and dispense.
Lot and unit-level recall execution with regulator notifications and partner workflows.
Standards-based EPCIS exchange with trading partners and regulators — no rebuild for every new partner.
Real-time visibility of inventory, holds and chain-of-custody exceptions.
Signed events expose tampering or insertion attempts immediately — not in next quarter's audit.
Outcomes
Surgical recall execution and counterfeit detection at unit level.
Packaged in the formats regulators already understand — no last-minute scramble.
Standards-based exchange replaces bespoke partner integrations.
Powered by
Halo ID
GS1 Digital Link, DPP-ready
More industries


Industry
Make audits faster, evidence richer and certificates verifiable.
Book a 30-minute walkthrough and we'll show you Haloglide running on your kind of supply chain.